Category: Lillyfunded
-
Zepbound (tirzepatide) superior to Wegovy (semaglutide), says Lilly-funded clinical trial
•
In the midst of the war on obesity, a clear winner has emerged in the battle between two weight-loss injections. Zepbound (tirzepatide), made by Fortune 500 company Eli Lilly & Co., outperformed competitor Wegovy (semaglutide), a Novo Nordisk Top 500 product, in a recent study Randomized clinical trial Supported by…